Authors


Paul Feuerstadt, MD

Latest:

Restoring Balance with Advanced Fecal Microbiota Transplantation in C. difficile Infections

Dr Paul Feuerstadt joins Dr David Hudesmand and Dr Jordan Axelrad in a discussion about treatment approaches for C difficile infections, and the latest advances in treating recurrent infections with fecal microbiota transplantation.


Adam Friedman, MD, FAAD, The George Washington School of Medicine & Health Sciences

Latest:

COVID-19 and Payor Strategies for Non-Medical Switching

Adam Friedman, MD, FAAD discusses how payors accelerated non-medical switching during COVID-19 and how healthcare providers can respond to new challenges. 


Seenu Hariprasad, MD

Latest:

Perspectives on Loading Dose Recommendations for New Therapies

Experts discuss the practice of loading doses for newer agents and when they would consider this suitable for patients.


Robert Busch, MD

Latest:

Protecting Cardiorenal Function In Diabetic Kidney Disease

Dhiren Patel, PharmD, and Bob Busch, MD, interview Fatima Cody Stanford, MD, MPH, MPA, an obesity medicine specialist, to examine the cardiovascular (CV) impact of obesity and delve into the potential benefits of newer weight loss medications in mitigating CV risk and heart failure.



Jayanth Sridhar, MD

Latest:

Advice to Physicians Treating Geographic Atrophy

Drs Eleonora M. Lad, David R. Lally, Jaynath R. Sridhar, and Nancy M. Holekamp share takeaways for health care professionals taking care of patients with geographic atrophy and earlier stages of age-related macular degeneration.


Robin S. Goland, MD

Latest:

Strategies to Improve Screening and Diagnosis of T1D

Drs Robert Busch, Robin S. Goland, Kimberly Simmons, and Teresa Quattrin discuss strategies to facilitate screening of type 1 diabetes and improve management of disease.



J. Scott Boswell, MD

Latest:

Treatment of Generalized Pustular Psoriasis (GPP)

Kanya Oul shares how her generalized pustular psoriasis (GPP) was initially treated and Drs Tina Bhutani and Scott Boswell discuss available treatment options for GPP.


James A. McKinnell, MD

Latest:

Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.


Lawrence F. Eichenfield, MD, Rady Children’s Hospital-San Diego

Latest:

Emerging Agents for the Treatment of Atopic Dermatitis

Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.


Barbara Kennedy, MHA, FACHE

Latest:

Leading Through Twin Healthcare Crises

Stress induced by COVID-19 is driving opioid addiction risks. An expert weighs in on addressing one matter to resolve another.



James Januzzi, MD

Latest:

REMS Program Resources for Clinicians

An expert cardiologist discusses the importance of healthcare provider education and finding resources around the REMS program.


Abigail Brooks, MA

Latest:

DAA Use Increased After State Medicaid Programs Eased HCV Treatment Restrictions

The modified difference-in-differences analysis found notable increases in DAA use after state Medicaid programs relaxed certain coverage restrictions.



Lauren Miller, MPAS, PA-C

Latest:

A Patient-Centric Medcast on The Journey Through Moderate Plaque Psoriasis

Advanced practice providers in dermatology discuss exciting developments in the treatment landscape of plaque psoriasis. Listen to their insights into the often-challenging journey patients go on. The arrival of novel oral systemic treatment options offers opportunities to alleviate the burden of this chronic disease.


Sagar V Parikh, MD, FRCPC

Latest:

Improving Awareness for Depressive Disorders

Andrew J Cutler, MD; Gregory Mattingly, MD; and Sagar V. Parikh, MD, FRCPC, comment on the need to improve awareness around depressive disorders and break the stigma of mental health treatment.


Kimberly A. Brown, MD

Latest:

Counseling Patients on Managing Medication in HE

Hepatology experts discuss educating patients with hepatic encephalopathy on managing medications and supplements.



Douglas DiRuggiero, DMSc, PA-C, Skin Cancer and Cosmetic Dermatology Center

Latest:

Clinical Pearls and Educational Needs in Plaque Psoriasis

Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.


Jennifer Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP

Latest:

Efficacy of Prescription Vs OTC Fish Oil Products

What pharmacists and providers need to know to counsel patients on when discussing the use of prescription or over-the-counter fish oil supplement as treatment for dyslipidemia and hypertriglyceridemia.




Lisa Harding, MD

Latest:

Integrated Care and Treatment-Resistant Depression

Closing thoughts regarding a discussion on improving the management of patients with treatment-resistant depression using newer treatment approaches in a more standardized fashion.


Elna Saah, MD

Latest:

Practice Pearls for the Management of SCD

A panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.


Derek Jones

Latest:

Biggest Challenges Nurses Faced In 2021 And How To Become More Resilient In The Future

Burnout problems persisted prior to the COVID-19 pandemic, but have been made worse since the beginning of the pandemic.


Michele M Cerra, MSN, FNP-C

Latest:

Managing PsA During the COVID-19 Pandemic

Before closing out their discussion on psoriatic arthritis management, two experts consider how the COVID-19 pandemic has affected their practice.



Joseph Sullivan, MD, and Mary Anne Meskis

Latest:

Ensuring Continuity of Care for Rare, Catastrophic Forms of Epilepsy During COVID-19

Families of patients with Dravet syndrome and other rare epileptic burdens have lived under amplified fear this year. That is why telemedicine is a more vital tool than ever.

© 2024 MJH Life Sciences

All rights reserved.